|
|
| AMT-240 / uniQure (0 Trials) |
|
| AMT-253 / Suzhou Maximum Bio-tech (0 Trials) |
|
| AMT-260 / uniQure (0 Trials) |
|
| AMT2003 / Auron Healthcare (0 Trials) |
|
| Amtagvi (lifileucel) / Iovance Biotherap (11 Trials) |
|
| Amtericin (amphotericin B Injection) / VHB Life Sci (0 Trials) |
|
| AMTX-100 CF3 / Amytrx Therap (0 Trials) |
|
| amubarvimab (BRII-196) / Brii Biosci (0 Trials) |
|
| amulirafusp alfa (IMM0306) / ImmuneOnco Biopharma (0 Trials) |
|
| AMUN-003 / AmunBio (0 Trials) |
|
| amuvatinib (MP470) / Otsuka (0 Trials) |
|
| AMV-STT1 / Affimed (0 Trials) |
|
| AMV-STT2 / Affimed (0 Trials) |
|
| Amvuttra (vutrisiran) / Alnylam (0 Trials) |
|
| AMX0114 / Amylyx (0 Trials) |
|
| AMXI-2001 / AtlasMedx (0 Trials) |
|
| AMXI-3001 / AtlasMedx (0 Trials) |
|
| AMXI-5001 / AtlasMedx (0 Trials) |
|
| AMXT 1501 / Aminex Therap (0 Trials) |
|
| AMY-101 / Amyndas (0 Trials) |
|
| AMY109 / Roche (0 Trials) |
|
| amycretin oral (NN9487 oral) / Novo Nordisk (0 Trials) |
|
| amylin long acting (AZD6234) / AstraZeneca (0 Trials) |
|
| Amyloid β inhibitor / Wren Therap (0 Trials) |
|
| AMZ002 / Amzell, Nordic Group (0 Trials) |
|
| Amzeeq (minocycline topical foam 4%) / Fortress (1 Trials) |
|
| AN-0128 / Pfizer (0 Trials) |
|
| AN0015 / Adlai Nortye (0 Trials) |
|
| AN1005 / Adlai Nortye, Xiamen Biotime Biotech (0 Trials) |
|
| AN1792 / J&J, Pfizer (0 Trials) |
|
| AN2718 / Pfizer, GSK (0 Trials) |
|
| AN2898 / Pfizer (0 Trials) |
|
| AN3025 / Adlai Nortye (0 Trials) |
|
| AN3485 / Pfizer (0 Trials) |
|
| AN4005 / Adlai Nortye (0 Trials) |
|
| AN4161 / Pfizer (0 Trials) |
|
| AN6001 / Saniona (0 Trials) |
|
| AN6015 / Adlai Nortye, Xiamen Biotime Biotech (0 Trials) |
|
| AN6025 / Adlai Nortye (0 Trials) |
|
| AN6414 / Pfizer (0 Trials) |
|
| AN9015 / Adlai Nortye (0 Trials) |
|
| anacetrapib (MK-0859) / Merck (MSD) (1 Trials) |
|
| Anact C (freeze-dried human activated protein C concentrate) / Meiji Seika (0 Trials) |
|
| Anaferon / Materia Medica, EastGate Biotech (0 Trials) |
|
| anagrelide (ALA-018) / Arovella Therap (0 Trials) |
|
| anagrelide (SAR001) / Sartar Therap (0 Trials) |
|
| anagrelide CR (GALE-401) / SELLAS Life Sciences (0 Trials) |
|
| Analsik (diazepam/metamizole) / Sanbe (0 Trials) |
|
| anandamide (HT-005) / Zylo Therap (0 Trials) |
|
| Anaphylm (epinephrine) / Aquestive (0 Trials) |
|
| anaprazole / Sihuan Pharmaceutical (0 Trials) |
|
| Anapsos / Asacpharma (0 Trials) |
|
| anastrozole / Generic mfg. (124 Trials) |
|
| anastrozole/levonorgestrel (BAY 98-7196) / Bayer (0 Trials) |
|
| anatabine (RCP-006) / Rock Creek Pharma (0 Trials) |
|
| Anathromb (anagrelide CR) / AOP Orphan Pharma (0 Trials) |
|
| Anavex 1-41 / Anavex (0 Trials) |
|
| ANAVEX 3-71 / Anavex (1 Trials) |
|
| Anavex Plus (blarcamsine/donepezil) / Anavex (0 Trials) |
|
| ANAVEX1066 / Anavex (0 Trials) |
|
| ANB004 / AnaptysBio (0 Trials) |
|
| ANB032 / AnaptysBio (0 Trials) |
|
| ANB033 / AnaptysBio (0 Trials) |
|
| ANB101 / AnaptysBio (0 Trials) |
|
| AnBaiNuo (etanercept biosimilar) / Zhejiang Hisun (2 Trials) |
|
| Anbeisi (bevacizumab biosimilar) / Sino Biopharm (0 Trials) |
|
| anbenitamab (KN026) / Alphamab (0 Trials) |
|
| Anbesol (lidocaine/chlorocresol/cetylpyridinium) / Alliance (0 Trials) |
|
| Anboni (unecritinib) / Sino Biopharm (0 Trials) |
|
| ANC-501 / Aditum Bio (0 Trials) |
|
| Ancain (omfiloctocog alfa) / Sinocelltech (2 Trials) |
|
| Ancer-20 (Z-100) / Zeria Pharma (0 Trials) |
|
| ancremonam (BOS-228) / Boston Pharma (0 Trials) |
|
| AND-378 / Neuropathix (0 Trials) |
|
| AND-383 / Neuropathix (0 Trials) |
|
| AND017 / Hangzhou Andao Pharma (0 Trials) |
|
| AND019 / Hangzhou Andao Pharma (0 Trials) |
|
| andecaliximab (GS-5745) / Gilead (1 Trials) |
|
| Andembry (garadacimab) / CSL Behring (0 Trials) |
|
| Andewei (benmelstobart) / Apollomics (1 Trials) |
|
| AndexXa (coagulation factor Xa (recombinant), inactivated -zhzo) / Daiichi Sankyo, AstraZeneca (5 Trials) |
|
| andolast (CR2039) / Viatris (0 Trials) |
|
| Androgen receptor degradation agents / Eledon (0 Trials) |
|
| Androxal (enclomifene) / AbbVie (0 Trials) |
|
| ANEB-001 / Anebulo Pharma (1 Trials) |
|
| Anestho (thiopental) / Incepta Pharma (0 Trials) |
|
| anetumab ravtansine (BAY 94-9343) / Bayer (3 Trials) |
|
| ANF-Rho (pegfilgrastim biosimilar) / Prolong Pharma (1 Trials) |
|
| Anflu (trivalent influenza virus split vaccine) / Sinovac (0 Trials) |
|
| Anfoe (recombinant human erythropoietin biosimilar) / La Renon Healthcare (0 Trials) |
|
| ANG 1122 / Elicio Therap (0 Trials) |
|
| ANG 1170 / Elicio Therap (0 Trials) |
|
| ANG 3067 / Elicio Therap (0 Trials) |
|
| ANG 4011 / Elicio Therap (0 Trials) |
|
| ANG-2684 / Elicio Therap (0 Trials) |
|
| ANG-3038 / Elicio Therap (0 Trials) |
|
| ANG-3070 / Elicio Therap (2 Trials) |
|
| ANG-3281 / Elicio Therap (0 Trials) |
|
| ANG-3586 / Elicio Therap (0 Trials) |
|
| ANG-4021 / Elicio Therap (0 Trials) |
|
| ANG003 / Anagram Therap (0 Trials) |
|
| ANG1007 / Angiochem (0 Trials) |
|
| ANG2002 / Angiochem (0 Trials) |
|
| ANG4043 / Angiochem (0 Trials) |
|
| ANGE-S003 / Angecon Biotech (0 Trials) |
|
| Angeliq (drospirenone/17ß-estradiol) / Bayer (1 Trials) |
|
| Angikinase (urokinase biosimilar) / SEDICO (0 Trials) |
|
| Anginera (Epicardial angiogenesis patch) / Theregen (0 Trials) |
|
| AngioCal (40 kDA PEGylated anticalin) / Pieris Pharmaceuticals (0 Trials) |
|
| Angiocept (pegdinetanib) / BMS (0 Trials) |
|
| angiocidin / Protheragen (0 Trials) |
|
| Angiopoetin antibody / Boehringer Ingelheim, Sotio (0 Trials) |
|
| angiotensin-(1-7) / Erasme Hospital (0 Trials) |
|
| angiozyme (ABI-873) / Actis Biologics (0 Trials) |
|
| Anhengji (recombinant human coagulation factor VIII biosimilar) / Alphamab, Sino Biopharm (0 Trials) |
|
| anhydrous enol-oxaloacetate (AEO) / MetVital (0 Trials) |
|
| Anisina (ATM-3507) / Kazia (0 Trials) |
|
| anitocabtagene autoleucel (CART-ddBCMA) / Arcellx, Gilead (0 Trials) |
|
| Anjeso (meloxicam IV) / Baudax Bio (1 Trials) |
|
| Anjiarun (adalimumab biosimilar) / Sinocelltech (0 Trials) |
|
| ANK-700 / Anokion, BMS (0 Trials) |
|
| Ankeda (bevacizumab biosimilar) / Qilu Pharma (2 Trials) |
|
| Anktiva (nogapendekin alfa inbakicept-pmln) / ImmunityBio (30 Trials) |
|
| Anluoqing (envonalkib) / Sino Biopharm, Shouyao Holdings (0 Trials) |
|
| Anniko (penpulimab) / Akesobio, Sino Biopharm (1 Trials) |
|
| ANOC-001 / Anocca (0 Trials) |
|
| Anoro Ellipta (umeclidinium/vilanterol) / Innoviva, GSK (8 Trials) |
|
| ANP-303 / ANP Technologies (0 Trials) |
|
| ANP-601 / ANP Technologies, BMS (0 Trials) |
|
| ANPD001 / Aspen Neurosci (0 Trials) |
|
| ANPD002 / Aspen Neurosci (0 Trials) |
|
| Anpingxi (ripertamab) / Sinocelltech (2 Trials) |
|
| aNRP2-14 / aTyr Pharma (0 Trials) |
|
| Anruixi (zuberitamab) / Zhejiang Hisun (0 Trials) |
|
| anrukinzumab (IMA-638) / Pfizer (0 Trials) |
|
| ANS-6637 / Amygdala Neurosci (0 Trials) |
|
| anselamimab (CAEL-101) / AstraZeneca (0 Trials) |
|
| Ansimar (doxofylline) / ICE GROUP, Alitair Pharma (5 Trials) |
|
| ansipastobart (BR101) / Zhejiang Hisun (0 Trials) |
|
| Ansomone (somatrem biosimilar) / Anhui Anke Biotech (0 Trials) |
|
| ANT 3273 / Antabio (0 Trials) |
|
| ANT-043 / Antikor Biopharma (0 Trials) |
|
| ANT-045 / Antikor Biopharma (0 Trials) |
|
| ANT-401 / Aditum Bio (0 Trials) |
|
| ANT-429 / Antyra (0 Trials) |
|
| ANT2681 / Antabio (0 Trials) |
|
| ANT3310 / Antabio (0 Trials) |
|
| antaitavir hasophate (HEC74647PA) / HEC Pharm (0 Trials) |
|
| Antebate (betamethasone butyrate propionate) / Japan Tobacco (0 Trials) |
|
| antennapedia-P21 (TR1) / Trojantec (0 Trials) |
|
| antennapedia-P53 (TR2) / Trojantec (0 Trials) |
|
| Anterferon (interferon alpha 2b) / Anhui Anke Biotech (0 Trials) |
|
| Anthrasil (AIGIV) / Emergent Biosolutions (2 Trials) |
|
| Anthrasil (anthrax Immune Globulin) / Emergent Biosolutions (2 Trials) |
|
| Anti a–syn antibody / AC Immune (0 Trials) |
|
| anti CD19/CD22 CAR NK cells / Allife Medical Science and Technology (0 Trials) |
|
| Anti CEA/CD30 CAR-T / Shanghai First Song Therap (0 Trials) |
|
| Anti CTLA-4 mAb / Sutro Biopharma (0 Trials) |
|
| Anti D (human immunoglobulin anti-D) / AC Farma (0 Trials) |
|
| anti PD-L1 mAb / BMS (0 Trials) |
|
| anti TROP-2 antibody therapeutic / Roche (0 Trials) |
|
| anti κ CAR-T / Affiliated Hospital of Xuzhou Medical University (0 Trials) |
|
| anti- MESO CAR-T cells / Hrain Biotech (0 Trials) |
|
| anti-4-1BB scFv / Anaeropharma Science (0 Trials) |
|
| Anti-5T4 CAR-NK Cell Therapy / Imbioray Bio (0 Trials) |
|
| anti-ALK MAb / AstraZeneca (0 Trials) |
|
| Anti-ALPP CART Therapy / Innovative Cellular Therapeutics (0 Trials) |
|
| Anti-B7-H3 CAR-T cell therapy / Beijing Tiantan Hospital (0 Trials) |
|
| anti-B7H3-ATI020 / Anwita Biosci (0 Trials) |
|
| anti-BCMA CAR T cells / Allife Medical Science and Technology (0 Trials) |
|
| anti-BCMA CAR-T cell therapy / Sichuan Kelun Pharma (0 Trials) |
|
| anti-BCMA CAR-T cells / Hrain Biotech (0 Trials) |
|
| Anti-BCMA CAR-T cells / Sorrento (0 Trials) |
|
| anti-BCMA-CD19 CAR-NK cells / Sichuan Kelun Pharma (0 Trials) |
|
| anti-C5a immunotherapies / Resistentia (0 Trials) |
|
| anti-CA19-9/CEA CAR-T cell therapy / SMT Bio (0 Trials) |
|
| Anti-CCR4 antibody / Tizona Therap (0 Trials) |
|
| anti-CD117 CAR mRNA T cells / University of Zurich (0 Trials) |
|
| anti-CD123 CAR T-cell therapy / Bellicum (0 Trials) |
|
| anti-CD123 CAR-T / Wuhan Bio–Raid (0 Trials) |
|
| anti-CD137 mAb / Nanjing Galaxy Biopharma (0 Trials) |
|
| anti-CD138 CAR-T / Affiliated Hospital of Xuzhou Medical University (0 Trials) |
|
| Anti-CD19 CAR NK Cells / Allife Medical Science and Technology (0 Trials) |
|
| Anti-CD19 CAR-T / First Affiliated Hospital of Nanchang University (0 Trials) |
|
| anti-CD19 CAR-T cell / Shanghai Public Health Clinical Center (0 Trials) |
|
| anti-CD19 CAR-T cell therapy / Henan Hualong Biotech (0 Trials) |
|
| anti-CD19 CAR-T cell therapy / Bioceltech (0 Trials) |
|
| anti-CD19 CAR-T cell therapy / Tianjin Mycure Medical (0 Trials) |
|
| anti-CD19 CAR-T cell therapy / Zhongyuan Union Cell & Gene (0 Trials) |
|
| anti-CD19 CAR-T cell therapy / Wuhan Sian Medical Tech (0 Trials) |
|
| anti-CD19 CAR-T cell therapy / Shenzhen Innovation Immunotechnology (0 Trials) |
|
| anti-CD19 CAR-T cell therapy / Shanghai Children's Medical Center (0 Trials) |
|
| anti-CD19 CAR-T cell therapy / Gansu Provincial Hospital (0 Trials) |
|
| anti-CD19 CAR-T therapy / Wuhan Bio–Raid (0 Trials) |
|
| anti-CD19 DASH CAR-T / Hrain Biotech (0 Trials) |
|
| anti-CD19 iCAR NK cells / Allife Medical Science and Technology (0 Trials) |
|
| anti-CD19 mRNA CAR-T / Capstan Therap (0 Trials) |
|
| anti-CD19 UCAR-NK / Chongqing Precision Biotech (0 Trials) |
|
| anti-CD19 UCAR-T cells / AstraZeneca (0 Trials) |
|
| anti-CD19-CAR / Kecellitics Biotech (0 Trials) |
|
|